AbCellera Biologics Inc.

Historical 13F Holders

Symbol
ABCL
CUSIP
00288U106
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 00288U106 since 12/18/2024, largest first.

Filer % of Class Filed
Baker Bros. Advisors LP 13G/A
10.8% 5/7/2026
Event 4/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
Baillie Gifford & Co 13G/A 4.4% 10/9/2024
Event 9/30/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 12 9.89 M $138 M
2026 Q2 165 116 M $909 M
2026 Q1 152 124 M $434 M
2025 Q4 159 109 M $371 M
2025 Q3 157 104 M $525 M
2025 Q2 137 108 M $373 M
2025 Q1 137 136 M $304 M
2024 Q4 152 114 M $334 M
2024 Q3 146 106 M $275 M
2024 Q2 158 115 M $341 M
2024 Q1 165 122 M $553 M
2023 Q4 157 121 M $689 M
2023 Q3 150 120 M $552 M
2023 Q2 183 125 M $810 M
2023 Q1 196 130 M $982 M
2022 Q4 222 142 M $1.44 B
2022 Q3 213 133 M $1.32 B
2022 Q2 177 118 M $1.26 B
2022 Q1 145 113 M $1.10 B
2021 Q4 145 115 M $1.63 B
2021 Q3 138 98.7 M $1.98 B
2021 Q2 134 90.6 M $1.99 B
2021 Q1 94 71.2 M $2.42 B
2020 Q4 64 68.1 M $2.74 B